Anish Thomas1, Puskar Pattanayak2, Eva Szabo3, Paul Pinsky3. 1. Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address: anish.thomas@nih.gov. 2. Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD. 3. Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Abstract
BACKGROUND: Previous studies with a limited number of patients have reported divergent findings on whether screening can detect small cell lung cancer (SCLC) at an earlier stage and whether there might be a survival benefit. METHODS: This study examined the characteristics of SCLC detected by using low-dose CT (LDCT) screening in the National Lung Screening Trial, a randomized study of individuals at high risk for developing lung cancer comparingLDCT imaging vs chest radiography. SCLC was denoted as screen detected if diagnosed ≤ 1 year of a positive screen or after a longer period but with no time gap between diagnostic procedures of > 1 year; interval detected if diagnosed ≤ 1 year of a negative screen; and nonscreen detected if the subject did not receive any screens or otherwise as postscreening. RESULTS: A total of 143 cases of SCLC were diagnosed, including 49 (34.2%) screen detected, 15 (10.5%) interval detected, and 79 (55.2%) nonscreened/postscreening. Of the screening phase-diagnosed cases (ie, screen or interval detected), a higher proportion of SCLC cases compared with NSCLC cases were interval detected (23% vs 5%; P < .0001). A higher proportion of all SCLC cases compared with NSCLC cases were advanced stage (III/IV: 86% vs 36%; P < .0001). The unfavorable SCLC stage distribution extended across screen-detected (80% stage III/IV), interval-detected (86%), and nonscreened/postscreening (90%) cancers. Among screen-detected SCLC, only 63.3% had ≥ 1 noncalcified nodule in the cancer lobe compared with 85.4% of NSCLC cases (P < .0001). Even with very small LDCT screen-detected nodules, a high proportion of SCLC cases were late stage. There was no significant difference in survival between screen- and interval-detected or postscreening SCLC. CONCLUSIONS: "Early detection" with the use of LDCT imaging had no impact on SCLC outcomes. A successful screening modality should ideally detect SCLC earlier than when it can be detected on LDCT scans. Published by Elsevier Inc.
RCT Entities:
BACKGROUND: Previous studies with a limited number of patients have reported divergent findings on whether screening can detect small cell lung cancer (SCLC) at an earlier stage and whether there might be a survival benefit. METHODS: This study examined the characteristics of SCLC detected by using low-dose CT (LDCT) screening in the National Lung Screening Trial, a randomized study of individuals at high risk for developing lung cancer comparing LDCT imaging vs chest radiography. SCLC was denoted as screen detected if diagnosed ≤ 1 year of a positive screen or after a longer period but with no time gap between diagnostic procedures of > 1 year; interval detected if diagnosed ≤ 1 year of a negative screen; and nonscreen detected if the subject did not receive any screens or otherwise as postscreening. RESULTS: A total of 143 cases of SCLC were diagnosed, including 49 (34.2%) screen detected, 15 (10.5%) interval detected, and 79 (55.2%) nonscreened/postscreening. Of the screening phase-diagnosed cases (ie, screen or interval detected), a higher proportion of SCLC cases compared with NSCLC cases were interval detected (23% vs 5%; P < .0001). A higher proportion of all SCLC cases compared with NSCLC cases were advanced stage (III/IV: 86% vs 36%; P < .0001). The unfavorable SCLC stage distribution extended across screen-detected (80% stage III/IV), interval-detected (86%), and nonscreened/postscreening (90%) cancers. Among screen-detected SCLC, only 63.3% had ≥ 1 noncalcified nodule in the cancer lobe compared with 85.4% of NSCLC cases (P < .0001). Even with very small LDCT screen-detected nodules, a high proportion of SCLC cases were late stage. There was no significant difference in survival between screen- and interval-detected or postscreening SCLC. CONCLUSIONS: "Early detection" with the use of LDCT imaging had no impact on SCLC outcomes. A successful screening modality should ideally detect SCLC earlier than when it can be detected on LDCT scans. Published by Elsevier Inc.
Entities:
Keywords:
low-dose CT scan; lung cancer screening; non-small cell lung cancer; small cell lung cancer
Authors: John H M Austin; Rowena Yip; Belinda M D'Souza; David F Yankelevitz; Claudia I Henschke Journal: Lung Cancer Date: 2011-12-20 Impact factor: 5.705
Authors: F D Gilliland; N Joste; P M Stauber; W C Hunt; R Rosenberg; G Redlich; C R Key Journal: J Natl Cancer Inst Date: 2000-05-03 Impact factor: 13.506
Authors: Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks Journal: N Engl J Med Date: 2011-06-29 Impact factor: 91.245
Authors: Frances A Shepherd; John Crowley; Paul Van Houtte; Pieter E Postmus; Desmond Carney; Kari Chansky; Zeba Shaikh; Peter Goldstraw Journal: J Thorac Oncol Date: 2007-12 Impact factor: 15.609
Authors: Anish Thomas; Nobuyuki Takahashi; Vinodh N Rajapakse; Xiaohu Zhang; Yilun Sun; Michele Ceribelli; Kelli M Wilson; Yang Zhang; Erin Beck; Linda Sciuto; Samantha Nichols; Brian Elenbaas; Janusz Puc; Heike Dahmen; Astrid Zimmermann; Jillian Varonin; Christopher W Schultz; Sehyun Kim; Hirity Shimellis; Parth Desai; Carleen Klumpp-Thomas; Lu Chen; Jameson Travers; Crystal McKnight; Sam Michael; Zina Itkin; Sunmin Lee; Akira Yuno; Min-Jung Lee; Christophe E Redon; Jessica D Kindrick; Cody J Peer; Jun S Wei; Mirit I Aladjem; William Douglas Figg; Seth M Steinberg; Jane B Trepel; Frank T Zenke; Yves Pommier; Javed Khan; Craig J Thomas Journal: Cancer Cell Date: 2021-04-12 Impact factor: 31.743
Authors: Nitin Roper; Moises J Velez; Alberto Chiappori; Yoo Sun Kim; Jun S Wei; Sivasish Sindiri; Nobuyuki Takahashi; Deborah Mulford; Suresh Kumar; Kris Ylaya; Christopher Trindade; Irena Manukyan; Anna-Leigh Brown; Jane B Trepel; Jung-Min Lee; Stephen Hewitt; Javed Khan; Anish Thomas Journal: Nat Commun Date: 2021-06-23 Impact factor: 14.919